{"product_id":"markers-in-cardiology-isbn-9781405134187","title":"Markers in Cardiology","description":"With the rapid development of the field of cardiac biomarkers comes a need for updated guidance on how to use them clinically. Drs. Adams, Jaffe, and Apple meet that need with this timely reference.\u003cbr\u003e \u003cp\u003eTaking a case-oriented approach for the greatest clinical relevance, the book bridges the gap between science and practice. If you use – or want to use – cardiac markers such as BNP and troponin to help your patients, you will find this clear and comprehensive reference provides a dependable source of valuable information.\u003cbr\u003e \u003c\/p\u003e \u003cp\u003eThe 19 chapters are divided into three parts:\u003cbr\u003e \u003c\/p\u003e \u003cp\u003e• Cardiac Troponins\u003cbr\u003e • Natriuretic Peptides\u003cbr\u003e • Contemporary Markers of Risk\u003cbr\u003e \u003c\/p\u003e \u003cp\u003eThe authors cover the technical, clinical, and outcome assessments for each marker used in clinical practice. After each case scenario, an extensive discussion explains the clinical decisions and provides valuable context.\u003c\/p\u003e  Contents. \u003cp\u003eContributors.\u003c\/p\u003e \u003cp\u003ePreface.\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 1 Cardiac troponins\u003c\/b\u003e.\u003c\/p\u003e \u003cp\u003e1 Basics of cardiac troponin: practical aspects of assays, potential.\u003c\/p\u003e \u003cp\u003eanalytical confounders, and clinical interpretation.\u003c\/p\u003e \u003cp\u003eFred S. Apple (University of Minnesota School of Medicine).\u003c\/p\u003e \u003cp\u003e2 Diagnostic use of cardiac troponins in ST-segment elevation.\u003c\/p\u003e \u003cp\u003emyocardial infarction.\u003c\/p\u003e \u003cp\u003eSusanne Korff (Medizinische Universitätsklinik Heidelberg), Hugo A. Katus (Department of Cardiology), Evangelos Giannitsis (Department of Cardiology).\u003c\/p\u003e \u003cp\u003e3 Therapeutic implications of cardiac troponins in ST-segment.\u003c\/p\u003e \u003cp\u003eelevation and non-ST-segment elevation myocardial.\u003c\/p\u003e \u003cp\u003einfarction.\u003c\/p\u003e \u003cp\u003eTracy Y. Wang, John M. Castor, L. Kristin Newby.\u003c\/p\u003e \u003cp\u003e4 Ischemic heart disease in the absence of overt coronary.\u003c\/p\u003e \u003cp\u003eartery disease.\u003c\/p\u003e \u003cp\u003eAllan S. Jaffe (Mayo Clinic).\u003c\/p\u003e \u003cp\u003e5 So you think you have a “false positive’’ troponin?.\u003c\/p\u003e \u003cp\u003eJesse E. Adams (Jewish Hospital Heart and Lung Institute).\u003c\/p\u003e \u003cp\u003e6 Use of cardiac troponin in patients in non-ischemic pathologies.\u003c\/p\u003e \u003cp\u003eand exposure to environmental toxins.\u003c\/p\u003e \u003cp\u003eFred S. Apple (University of Minnesota School of Medicine).\u003c\/p\u003e \u003cp\u003e7 Cardiac troponins in patients with congestive heart failure.\u003c\/p\u003e \u003cp\u003eJesse Adams (Jewish Hospital Heart and Lung Institute).\u003c\/p\u003e \u003cp\u003e8 Troponins and the critically Ill patient.\u003c\/p\u003e \u003cp\u003eJose Antonio Perez (Mayo Clinic \u0026amp; Medical School), Luciano Babuin (Cardiovascular Division \u0026amp; Cardiovascular), Allan S. Jaffe (Mayo Clinic).\u003c\/p\u003e \u003cp\u003e9 Cardiac troponins and renal failure.\u003c\/p\u003e \u003cp\u003eSuresh Pothuru (University of Maryland), Christopher deFilippi (University of Maryland).\u003c\/p\u003e \u003cp\u003e10 Cardiac biomarkers: detection of in-hospital myocardial.\u003c\/p\u003e \u003cp\u003ereinfarction.\u003c\/p\u003e \u003cp\u003eFred S. Apple (University of Minnesota School of Medicine).\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 2 Natriuretic peptides\u003c\/b\u003e.\u003c\/p\u003e \u003cp\u003e11 The future: interpreting new guidelines for myocardial.\u003c\/p\u003e \u003cp\u003einfarction.\u003c\/p\u003e \u003cp\u003eAllan S. Jaffe (Mayo Clinic).\u003c\/p\u003e \u003cp\u003e12 Basics of natriuretic peptides: practical aspects of assays,.\u003c\/p\u003e \u003cp\u003epotential analytical confounders, and clinical interpretation.\u003c\/p\u003e \u003cp\u003eAlan H.B. Wu (San Francisco General Hospital).\u003c\/p\u003e \u003cp\u003e13 Natriruetic peptides in clinical practice.\u003c\/p\u003e \u003cp\u003eAlan Maisel (University of California).\u003c\/p\u003e \u003cp\u003e14 Outpatient evaluation for cardiovascular diseases using.\u003c\/p\u003e \u003cp\u003enatriuretic peptide testing.\u003c\/p\u003e \u003cp\u003eAaron L. Baggish (Massachusetts General Hospital), James L. Januzzi (Harvard Medical School).\u003c\/p\u003e \u003cp\u003e15 Natriuretic peptides in patients with renal failure.\u003c\/p\u003e \u003cp\u003ePeter A. McCullough (William Beaumont Hospital).\u003c\/p\u003e \u003cp\u003e16 Congestive heart failure: treatment implications of natriuretic.\u003c\/p\u003e \u003cp\u003epeptides.\u003c\/p\u003e \u003cp\u003eW Frank Peacock (Emergency Cardiology Research).\u003c\/p\u003e \u003cp\u003e17 Utilizing multimarker strategies in patients who present with.\u003c\/p\u003e \u003cp\u003econgestive heart failure.\u003c\/p\u003e \u003cp\u003eJohannes Mair (Universitaetsklinik fuer Innere Medizin).\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 3 Contemporary markers of risk\u003c\/b\u003e.\u003c\/p\u003e \u003cp\u003e18 Clinical integration of C-reactive protein for primary and.\u003c\/p\u003e \u003cp\u003esecondary risk factor stratification.\u003c\/p\u003e \u003cp\u003eJesse E. Adams (Jewish Hospital Heart and Lung Institute).\u003c\/p\u003e \u003cp\u003e19 Lipoprotein subfraction analysis using nuclear magnetic.\u003c\/p\u003e \u003cp\u003eresonance spectroscopy.\u003c\/p\u003e \u003cp\u003eWilliam C. Cromwell (Presbyterian Center for Preventive Cardiology), Harold E. Bays (L-Marc Research Center), Peter P. Toth (Director of Preventive Cardiology).\u003c\/p\u003e \u003cp\u003eIndex\u003c\/p\u003e \"I think this is a good book and good value for money. It is fairly light reading and I found myself wanting to make notes and use it as a point of reference as it pulls things together well. Therefore, I would recommend it to others.\" (\u003ci\u003eCardiology News\u003c\/i\u003e, February 2009)  \u003cb\u003eJesse E. Adams, MD FACC\u003cbr\u003e \u003c\/b\u003eUniversity of Louisville\u003cbr\u003e Division of Cardiology\u003cbr\u003e 100 Mallard Creek\u003cbr\u003e Louisville, KY 40202\u003cbr\u003e USA\u003cbr\u003e \u003cp\u003e\u003cbr\u003e \u003cb\u003eFred Apple, PhD\u003cbr\u003e \u003c\/b\u003eDepartment of Laboratory Medicine and Pathology\u003cbr\u003e Hennepin County Medical Center and University of Minnesota School of Medicine\u003cbr\u003e Minneapolis, MN\u003cbr\u003e USA\u003cbr\u003e \u003c\/p\u003e \u003cp\u003e\u003cbr\u003e \u003cb\u003eAllan\u003c\/b\u003e \u003cb\u003eS. Jaffe, MD\u003cbr\u003e \u003c\/b\u003eCardiovascular Division and Cardiovascular Research Institute and Division of Laboratory Medicine\u003cbr\u003e Mayo Clinic and Medical School\u003cbr\u003e Rochester, Minnesota\u003cbr\u003e USA\u003c\/p\u003e  With the rapid development of the field of cardiac biomarkers comes a need for updated guidance on how to use them clinically. Drs. Adams, Jaffe, and Apple meet that need with this timely reference.\u003cbr\u003e \u003cp\u003eTaking a case-oriented approach for the greatest clinical relevance, the book bridges the gap between science and practice. If you use – or want to use – cardiac markers such as BNP and troponin to help your patients, you will find this clear and comprehensive reference provides a dependable source of valuable information.\u003cbr\u003e \u003c\/p\u003e \u003cp\u003eThe 19 chapters are divided into three parts:\u003cbr\u003e \u003c\/p\u003e \u003cp\u003e• Cardiac Troponins\u003cbr\u003e • Natriuretic Peptides\u003cbr\u003e • Contemporary Markers of Risk\u003cbr\u003e \u003c\/p\u003e \u003cp\u003eThe authors cover the technical, clinical, and outcome assessments for each marker used in clinical practice. After each case scenario, an extensive discussion explains the clinical decisions and provides valuable context.\u003c\/p\u003e","brand":"Wiley-Blackwell","offers":[{"title":"Default Title","offer_id":47989573550309,"sku":"NP9781405134187","price":134.95,"currency_code":"USD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1842\/7735\/files\/9781405134187.jpg?v=1761784653","url":"https:\/\/k12savings.com\/es\/products\/markers-in-cardiology-isbn-9781405134187","provider":"K12savings","version":"1.0","type":"link"}